Navana Pharma allowed to issue Tk150cr bond | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
July 22, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, JULY 22, 2025
Navana Pharma allowed to issue Tk150cr bond

Stocks

TBS Report
09 November, 2023, 09:30 pm
Last modified: 09 November, 2023, 09:35 pm

Related News

  • Govt mulls OMS sale of potatoes to ensure fair prices for farmers
  • Bodies of 3 killed in Gopalganj exhumed on court orders, sent to hospital morgue
  • Questions raised over training jets flying above crowded city
  • Inside the Milestone school plane crash: What kind of aircraft was it?
  • Election under PR system will open door to extremism in Bangladesh: Tarique Rahman

Navana Pharma allowed to issue Tk150cr bond

The company wants to raise the fund for its loan repayment

TBS Report
09 November, 2023, 09:30 pm
Last modified: 09 November, 2023, 09:35 pm
Navana Pharma allowed to issue Tk150cr bond

The securities regulator, in a meeting held on Thursday, has allowed Navana Pharmaceuticals Limited to issue a bond worth Tk150 crore with a maturity period of five years. 

The company wants to raise the fund for its loan repayment. 

In a press release, the Bangladesh Securities and Exchange Commission (BSEC) stated the nature of the bond is unsecured and 60% convertible into the company's equity. The range of the coupon rate is 8-10%. 

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The bond will be privately placed among investors and they would receive interests twice a year.

The BSEC also stated that Navana Pharma's bond will be listed on the Alternative Trading Board so that investors can trade it in the secondary market.

Prime Bank Investment will act as trustee and City Bank Capital Resources as arranger of the bond.

Earlier, Company Secretary Joynul Abedin said, "The bond will strengthen our financial position and provide us with the necessary capital to pursue our growth strategies."

"It would help save some interest expenses as the cost of bond capital would be lower than that of bank loans."

The company would also enjoy a better cash flow as bond interest would be paid once in every six months while bank loans are paid back in monthly installments, he added. 

As of 31 March, Navana Pharmaceuticals has a bank liability of Tk330 crore.

Earlier, it had paid back Tk21.18 crore bank loans out of the capital it collected from the investors through an initial public offering last year.

Meanwhile, the drug maker has recommended a 13% cash dividend to its shareholders for the fiscal 2022-23.

At the end of FY23, its earnings per share stood at Tk3.59 and net asset value per share at Tk40.71.

Navana Pharmaceuticals shares, having a face value of Tk10 apiece, fell by 2.31% to Tk86.70 at the Dhaka bourse on Thursday, compared to the previous trading session.

Top News

Navana Pharma / Stock Market / Bangladesh / Bond

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Syed Zakir Hossain/TBS
    Students dispersed from Secretariat, now assembling in Stadium Market area
  • Photo: Collected
    2 advisers, CA press secy leave Milestone School 'through backdoor exit' amid protests
  • Photo: TBS
    Milestone plane crash: 69 still hospitalised, death toll stands at 31

MOST VIEWED

  • Training aircraft crashes at the Diabari campus of Milestone College on 21 July 2025. Photo: Courtesy
    BAF jet crash at Milestone school: At least 20 including children, pilot dead; 171 hospitalised
  • Flight Lieutenant Md Towkir Islam. Photo: Collected
    Pilot tried to avoid disaster by steering crashing jet away from populated area: ISPR
  • An idle luxury: Built at a cost of Tk450 crore, this rest house near Parki Beach in Anwara upazila has stood unused for six months. Perched on the southern bank of the Karnaphuli, the facility now awaits a private lease as the Bridge Division seeks to put it to use. Photo: Md Minhaz Uddin
    Karnaphuli Tunnel’s service area holds tourism promises, but tall order ahead
  • Bangladesh declares one-day state mourning following plane crash on school campus
    Bangladesh declares one-day state mourning following plane crash on school campus
  • 91-day treasury bills rate falls 1.13 percentage points to 10.45% in a week
    91-day treasury bills rate falls 1.13 percentage points to 10.45% in a week
  • Air Force F-7 BJI training aircraft crashes at Milestone College in Uttara
    Air Force F-7 BJI training aircraft crashes at Milestone College in Uttara

Related News

  • Govt mulls OMS sale of potatoes to ensure fair prices for farmers
  • Bodies of 3 killed in Gopalganj exhumed on court orders, sent to hospital morgue
  • Questions raised over training jets flying above crowded city
  • Inside the Milestone school plane crash: What kind of aircraft was it?
  • Election under PR system will open door to extremism in Bangladesh: Tarique Rahman

Features

Photo: Mehedi Hasan/TBS

Milestone plane crash: Aggrieved nation left with questions as citizens rally to help

3h | Panorama
Illustration: TBS

Uttara, Jatrabari, Savar and more: The killing fields that ran red with July martyrs’ blood

19h | Panorama
Despite all the adversities, girls from the hill districts are consistently pushing the boundaries to earn repute and make the nation proud. Photos: TBS

Ghagra: Where dreams rise from dust for Bangladesh women's football

2d | Panorama
Photos: Collected

Water-resistant footwear: A splash of style in every step

2d | Brands

More Videos from TBS

Tariff deal: Dhaka to submit draft today, US yet to confirm meeting date

Tariff deal: Dhaka to submit draft today, US yet to confirm meeting date

14m | TBS Insight
No scope for hiding information: Air Force chief

No scope for hiding information: Air Force chief

49m | TBS Today
Students complain about not reporting the exact number of bodies

Students complain about not reporting the exact number of bodies

1h | Videos
Education Secretary to be removed in the face of student protests

Education Secretary to be removed in the face of student protests

1h | TBS News Updates
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net